8-K: Longeveron Faces Nasdaq Delisting Warning

Longeveron Inc. received a notice from Nasdaq regarding non-compliance with the $1.00 minimum bid price requirement for continued listing.

Summary

• Longeveron Inc. received a notice from The Nasdaq Stock Market on September 22, 2025, indicating non-compliance with the $1.00 minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)).
• The company's Class A common stock failed to meet this requirement due to its closing bid price for the last 30 consecutive business days.
• This notice does not result in immediate delisting; Longeveron has an initial 180-calendar-day period, until March 23, 2026, to regain compliance.
• Compliance can be regained if the bid price closes at $1.00 or more per share for a minimum of ten consecutive business days.
• A closing bid price of $0.10 or less for ten consecutive trading days before the compliance date could lead to immediate suspension and delisting.
• The company may be eligible for an additional 180-day compliance period if it meets other listing standards and notifies Nasdaq of its intention to cure the deficiency.

Sentiment

Score: 3

Explanation: The filing indicates a significant negative event for the company, specifically a notice of non-compliance with Nasdaq's minimum bid price requirement, which poses a direct threat to its continued listing. While a compliance period is granted, the underlying issue of a low stock price and the explicit lack of assurance for regaining compliance are strong negative indicators.

Negatives

• Received a notice from Nasdaq for failing to meet the $1.00 minimum bid price requirement for continued listing.
• Risk of immediate suspension and delisting if the stock price falls to $0.10 or less for ten consecutive trading days.
• No assurance that the company will be able to regain compliance with Nasdaq's listing requirements.

Risks

• Failure to regain compliance with the Nasdaq $1.00 minimum bid price requirement by March 23, 2026, could lead to delisting.
• Potential for immediate suspension and delisting if the common stock's closing bid price falls to $0.10 or less for ten consecutive trading days before the compliance date.
• Inability to meet other applicable Nasdaq listing rules, even if the minimum bid price is addressed.
• The company's ability to continue as a publicly traded entity on The Nasdaq Capital Market is uncertain.

Future Outlook

Longeveron Inc. intends to monitor the closing bid price of its Common Stock and assess available options to regain compliance with the Minimum Bid Price Requirement and continue listing on The Nasdaq Capital Market. However, there is no assurance that the company will be able to regain compliance or meet other applicable Nasdaq listing rules.

Management Comments

• The Company intends to monitor the closing bid price of the Common Stock and assess its available options to regain compliance with the Minimum Bid Price Requirement and continue listing on The Nasdaq Capital Market.

Industry Context

This announcement is specific to Longeveron's compliance with Nasdaq listing rules and does not directly reflect broader industry trends. However, small-cap biotechnology companies often face challenges in maintaining stock prices above minimum thresholds, especially during periods of market volatility or if clinical development milestones are not met as expected.

Stakeholder Impact

• Shareholders: Face increased risk of delisting, potential loss of liquidity, and reduced investor confidence, which could further depress share price.
• Employees: Potential uncertainty regarding the company's long-term stability and access to capital markets.
• Creditors: May view the company as higher risk, potentially impacting future financing terms.

Next Steps

• Monitor the closing bid price of the Common Stock.
• Assess available options to regain compliance with the Minimum Bid Price Requirement.
• Potentially provide written notice to Nasdaq of its intention to cure the deficiency if eligible for an additional compliance period.

Key Dates

Recommendation

The notice of non-compliance with Nasdaq's minimum bid price requirement is a severe negative signal, indicating fundamental issues with the company's market valuation and potentially its operational performance. While a compliance period exists, the explicit lack of assurance for regaining compliance, coupled with the risk of immediate delisting if the price falls below $0.10, suggests significant downside risk. Investors should consider selling to avoid further potential losses and reduced liquidity associated with a potential delisting.

Keywords

Longeveron, LGVN, Nasdaq, Delisting, Minimum Bid Price, Compliance, Stock Market, Biotechnology, SEC Filing, 8-K